Overview of Dr. Barrett
I am a board-certified gastroenterologist who specializes in General GI & inflammatory bowel disease (IBD). I am a tenured professor. I trained at University of Chicago (GI with a post-doc in Immunology) and moved to Northwestern University Hospital (NMH) where I was director of IBD and later division chief of GI. In 2013 I moved to the University of Kentucky where I am now division chief of G.I. and hepatology with a co-appointment in Microbiology / Immunology. My clinical interest is caring for severe refractory IBD. I have been funded through NIH and VA mechanisms x 30yr & currently study epithelial responses in colitis. The primary interest of our laboratory is the impact of mitochondrial respiration in regulating epithelial cell responses to mucosal ulceration in colitis (RO1-funded). This project led to the development of a novel drug (PCT patent pending), AuPhos, that increases mitochondrial function in the intestine and treats colitis (VA merit-funded).
Office
800 Rose St
Lexington, KY 40536Fax+1 859-257-8860
Education & Training
- University of ChicagoFellowship, Gastroenterology, 1986 - 1989
- Rush University Medical CenterResidency, Internal Medicine, 1983 - 1986
- University of Illinois College of MedicineClass of 1983
- University of Notre DameBS
Certifications & Licensure
- IL State Medical License 1983 - 2026
- KY State Medical License 2013 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Top Doctor Top Doctor Magazine, 2021
- AGA fellow American Gastroenterology Association, 2020
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Regulation of Mucosal Healing in Inflammatory Bowel Disease Start of enrollment: 2021 Apr 30
Publications & Presentations
PubMed
- 73 citationsAnti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice.Jae Geun Hyun, Goo Lee, Jeffrey B. Brown, Gery R. Grimm, Yueming Tang
Inflammatory Bowel Diseases. 2005-09-01 - 36 citationsLoss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis.Yang-An Wen, Xin Li, Tatiana Goretsky, Heidi L. Weiss, Terrence A. Barrett
Biochimica Et Biophysica Acta. 2015-10-01 - 92 citationsProapoptotic Bid is required for pulmonary fibrosisG. R. Scott Budinger, Gökhan M. Mutlu, James Eisenbart, Alyson C. Fuller, Amy Bellmeyer
Proceedings of the National Academy of Sciences of the United States of America. 2006-03-21
Press Mentions
- ‘You Get So Much Out of It in Return’: UK Physicians Speak of Fulfilling Experience Volunteering at Salvation Army ClinicDecember 11th, 2022
- Why Your Burps Smell like Rotten Eggs, and What to Do About ItJanuary 29th, 2021
- BPG Is Committed to Discovery and Dissemination of KnowledgeJuly 28th, 2017
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO PlatinumFirst Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: